Also trades as: LSBCF (OTC) · $vol 0M
LSB NASDAQ
LakeShore Biopharma Co., Ltd
1W: +1.3%
1M: -2.7%
3M: -25.0%
1Y: -79.4%
3Y: -99.2%
$0.63
Last traded 2025-10-16 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$577M
Revenue
+19.9% YoY
$-434M
Net Income
-201.6% YoY
$-265M
Free Cash Flow
-25.7% YoY
25.4%
Gross Margin
-133.7%
Op. Margin
-133.9%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-66.0%
ROA-26.8%
ROIC-46.1%
Valuation
P/E-4.5
P/B0.9
EV/EBITDA0.0
Leverage
Debt/Equity0.73
Current Ratio1.13
Interest Cov.-7.1x
Quality Scores
Piotroski F3/9
Altman Z—
Beneish M-1.86